This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, September 15, 2008
FDA accepts for review the Complete Response to ceftobiprole NDA Approvable Letter
Basilea Pharmaceutica Ltd. announces that the Food and Drug Administration (FDA) has accepted for review the Complete Response to the ceftobiprole New Drug Application (NDA) Approvable Letter.
No comments:
Post a Comment